Inventor
EDMONDSON SCOTT D
US37 patents
⚠️ This page may combine multiple inventors who share the name “EDMONDSON SCOTT D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK SHARP & DOHME
18 patentsUS8354403B2Jan 15, 2013
Pyrrolidine derived beta 3 adrenergic receptor agonists
MERCK SHARP & DOHME15 citations82
US10123995B2Nov 13, 2018
Factor XIa inhibitors
MERCK SHARP & DOHME2 citations72
US10011585B2Jul 3, 2018
Factor XIa inhibitors
MERCK SHARP & DOHME2 citations72
US9868727B2Jan 16, 2018
Factor XIa inhibitors
MERCK SHARP & DOHME3 citations72
US9783530B2Oct 10, 2017
Factor Xla inhibitors
MERCK SHARP & DOHME2 citations72
US10093683B2Oct 9, 2018
Factor XIa inhibitors
MERCK SHARP & DOHME4 citations71
US10081617B2Sep 25, 2018
Factor XIa inhibitors
MERCK SHARP & DOHME2 citations70
US7718667B2May 18, 2010
Fused aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
MERCK SHARP & DOHME2 citations62
US10239863B2Mar 26, 2019
Factor XIa inhibitors
MERCK SHARP & DOHME1 citations61
US7884104B2Feb 8, 2011
Aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
MERCK SHARP & DOHME4 citations61
US9676723B2Jun 13, 2017
Factor XIa inhibitors
MERCK SHARP & DOHME1 citations50
US9663527B2May 30, 2017
Factor XIa inhibitors
MERCK SHARP & DOHME1 citations50
US10214512B2Feb 26, 2019
Factor XIA inhibitors
MERCK SHARP & DOHME0 citations41
US9975874B2May 22, 2018
Factor XIa inhibitors
MERCK SHARP & DOHME0 citations41
US8017624B2Sep 13, 2011
Fused aminopiperidines as dipeptidyi peptidase-IV inhibitors for the treatment or prevention of diabetes
MERCK SHARP & DOHME0 citations41
US7943615B2May 17, 2011
Fused aminopiperidines as dipeptidyl peptidase-4 inhibitors for the treatment or prevention of diabetes
MERCK SHARP & DOHME0 citations41
US7687492B2Mar 30, 2010
1,2,4-Oxadiazole derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
MERCK SHARP & DOHME0 citations41
US9944643B2Apr 17, 2018
Factor XIa inhibitors
MERCK SHARP & DOHME0 citations36
MERCK & CO INC
7 patentsUS6699871B2Mar 2, 2004
Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
MERCK & CO INC393 citations99
US7157490B2Jan 2, 2007
Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
MERCK & CO INC54 citations92
US7125873B2Oct 24, 2006
Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4, 3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
MERCK & CO INC29 citations92
US7208498B2Apr 24, 2007
Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes
MERCK & CO INC13 citations83
US7098239B2Aug 29, 2006
Dipeptidyl peptidase inhibitors for the treatment of diabetes
MERCK & CO INC12 citations82
US7332520B2Feb 19, 2008
Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
MERCK & CO INC1 citations52
US7456204B2Nov 25, 2008
Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
MERCK & CO INC0 citations41
BERGER RICHARD
5 patentsUS8247415B2Aug 21, 2012
Hydroxymethyl pyrrolidines as β3 adrenergic receptor agonists
BERGER RICHARD40 citations97
US8399480B2Mar 19, 2013
Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
BERGER RICHARD36 citations93
US8653260B2Feb 18, 2014
Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
BERGER RICHARD18 citations92
US8748433B2Jun 10, 2014
β3 adrenergic receptor agonists
BERGER RICHARD10 citations79
US8501786B2Aug 6, 2013
Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
BERGER RICHARD0 citations40
EDMONDSON SCOTT D
3 patentsUS8168637B2May 1, 2012
Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of diabetes
EDMONDSON SCOTT D4 citations72
US8440668B2May 14, 2013
Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of type 2 diabetes
EDMONDSON SCOTT D2 citations61
US8604038B2Dec 10, 2013
Pyrrolidine derived beta 3 adrenergic receptor agonists
EDMONDSON SCOTT D0 citations35